These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17218774)

  • 41. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
    Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
    Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma.
    Zhao P; Lu Y; Jiang X; Li X
    Cancer Sci; 2011 May; 102(5):1107-11. PubMed ID: 21276138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High apoptotic index correlates to p21 and p27 expression indicating a favorable outcome of primary breast cancer patients, but lacking prognostic significance in multivariate analysis.
    Schöndorf T; Göhring UJ; Becker M; Hoopmann M; Schmidt T; Rützel S; Rein DT; Ulrich U; Fechteler R; Bersch A; Mallmann P; Valter MM
    Pathobiology; 2004; 71(4):217-22. PubMed ID: 15263811
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BIN1 in cancer: biomarker and therapeutic target.
    Chen SY; Cao JL; Li KP; Wan S; Yang L
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7933-7944. PubMed ID: 36890396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
    Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
    BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
    Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
    Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel Colitis Immunotherapy Targets Bin1 and Improves Colon Cell Barrier Function.
    Thomas S; Mercado JM; DuHadaway J; DiGuilio K; Mullin JM; Prendergast GC
    Dig Dis Sci; 2016 Feb; 61(2):423-32. PubMed ID: 26195312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical implications of CSN6 protein expression and correlation with mutant-type P53 protein in breast cancer.
    Wang W; Tang M; Zhang L; Xu X; Qi X; Yang Y; Jin F; Chen B
    Jpn J Clin Oncol; 2013 Dec; 43(12):1170-6. PubMed ID: 24106298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma.
    Lv ZD; Zhang L; Liu XP; Jin LY; Dong Q; Li FN; Wang HB; Kong B
    Int J Clin Exp Pathol; 2015; 8(4):4015-21. PubMed ID: 26097589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of ultrasonographic features with NGX6 expression and prognosis in invasive ductal breast carcinoma.
    Xiao J; Zhou Y; Zhu W
    Int J Clin Exp Pathol; 2015; 8(6):6458-65. PubMed ID: 26261522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased expression of fibroblastic growth factor receptor 2 is correlated with poor prognosis in patients with breast cancer.
    Sun S; Jiang Y; Zhang G; Song H; Zhang X; Zhang Y; Liang X; Sun Q; Pang D
    J Surg Oncol; 2012 Jun; 105(8):773-9. PubMed ID: 22006548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
    Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
    Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator.
    Hudelist G; Czerwenka K; Kubista E; Marton E; Pischinger K; Singer CF
    Breast Cancer Res Treat; 2003 Mar; 78(2):193-204. PubMed ID: 12725419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Upregulated IL-19 in breast cancer promotes tumor progression and affects clinical outcome.
    Hsing CH; Cheng HC; Hsu YH; Chan CH; Yeh CH; Li CF; Chang MS
    Clin Cancer Res; 2012 Feb; 18(3):713-25. PubMed ID: 22186257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer.
    Choi HJ; Joo HS; Won HY; Min KW; Kim HY; Son T; Oh YH; Lee JY; Kong G
    J Natl Cancer Inst; 2018 Apr; 110(4):. PubMed ID: 29028222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of cyclooxygenase-2 in breast carcinogenesis and its relation to HER-2/neu and p53 protein expression in invasive ductal carcinoma.
    Cho MH; Yoon JH; Jaegal YJ; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Lee MC; Park CS; Woo Juhng S; Min KW
    Breast; 2006 Jun; 15(3):390-8. PubMed ID: 16169726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis].
    Zhang B; Liu FF; Ma YJ; Gu F
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):904-9. PubMed ID: 24506959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
    Liu C; Zhou S; Ke CS; Li NP; Wu RL
    Ai Zheng; 2007 Sep; 26(9):929-36. PubMed ID: 17927847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.
    Min KW; Kim DH; Do SI; Pyo JS; Chae SW; Sohn JH; Kim K; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kwon MJ; Moon KM
    Postgrad Med J; 2016 Dec; 92(1094):707-714. PubMed ID: 27222586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.